Literature DB >> 18095853

Inorganic materials for bone repair or replacement applications.

Audrey Hertz1, Ian J Bruce.   

Abstract

In recent years, excipient systems have been used increasingly in biomedicine in reconstructive and replacement surgery, as bone cements, drug-delivery vehicles and contrast agents. Particularly, interest has been growing in the development and application of controlled pore inorganic ceramic materials for use in bone-replacement and bone-repair roles and, in this context, attention has been focused on calcium-phosphate, bioactive glasses and SiO2- and TiO2-based materials. It has been shown that inorganic materials that most closely mimic bone structure and surface chemistry most closely function best in bone replacement/repair and, in particular, if a substance possesses a macroporous structure (pores and interconnections >100 microm diameter), then cell infiltration, bone growth and vascularization can all be promoted. The surface roughness and micro/mesoporosity of a material have also been observed to significantly influence its ability to promote apatite nucleation and cell attachment significantly. Pores (where present) can also be packed with pharmaceuticals and biomolecules (e.g., bone morphogenetic proteins [BMPs], which can stimulate bone formation). Finally, the most bio-efficient - in terms of collagen formation and apatite nucleation - materials are those that are able to provide soluble mineralizing species (Si, Ca, PO(4)) at their implant sites and/or are doped or have been surface-activated with specific functional groups. This article presents the context and latest advances in the field of bone-repair materials, especially with respect to the development of bioactive glasses and micro/mesoporous and macroporous inorganic scaffolds. It deals with the possible methods of preparing porous pure/doped or functionalized silicas or their composites, the studies that have been undertaken to evaluate their abilities to act as bone repair scaffolds and also presents future directions for work in that context.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18095853     DOI: 10.2217/17435889.2.6.899

Source DB:  PubMed          Journal:  Nanomedicine (Lond)        ISSN: 1743-5889            Impact factor:   5.307


  7 in total

1.  Induction of cytotoxicity by photoexcitation of TiO2 can prolong survival in glioma-bearing mice.

Authors:  Chao Wang; Shouqiang Cao; Xinxin Tie; Bo Qiu; Anhua Wu; Zhihong Zheng
Journal:  Mol Biol Rep       Date:  2010-03-30       Impact factor: 2.316

Review 2.  Biomaterials for tissue engineering.

Authors:  Esther J Lee; F Kurtis Kasper; Antonios G Mikos
Journal:  Ann Biomed Eng       Date:  2013-07-03       Impact factor: 3.934

3.  Antibacterial and Osteogenic Properties of Ag Nanoparticles and Ag/TiO2 Nanostructures Prepared by Atomic Layer Deposition.

Authors:  Denis Nazarov; Ilya Ezhov; Natalia Yudintceva; Maxim Shevtsov; Aida Rudakova; Vladimir Kalganov; Vladimir Tolmachev; Yuliya Zharova; Oleksiy Lutakov; Ludmila Kraeva; Elizaveta Rogacheva; Maxim Maximov
Journal:  J Funct Biomater       Date:  2022-05-18

4.  Nanostructured Biomaterials for Regeneration.

Authors:  Guobao Wei; Peter X Ma
Journal:  Adv Funct Mater       Date:  2008-11-24       Impact factor: 18.808

5.  Trehalose maintains bioactivity and promotes sustained release of BMP-2 from lyophilized CDHA scaffolds for enhanced osteogenesis in vitro and in vivo.

Authors:  Jun Zhao; Shaoyi Wang; Jianqiang Bao; Xiaojuan Sun; Xiaochen Zhang; Xiuli Zhang; Dongxia Ye; Jie Wei; Changsheng Liu; Xinquan Jiang; Gang Shen; Zhiyuan Zhang
Journal:  PLoS One       Date:  2013-01-24       Impact factor: 3.240

6.  Nanocalcium-deficient hydroxyapatite-poly (e-caprolactone)-polyethylene glycol-poly (e-caprolactone) composite scaffolds.

Authors:  Zhiwei Wang; Ming Li; Baoqing Yu; Liehu Cao; Qingsong Yang; Jiacan Su
Journal:  Int J Nanomedicine       Date:  2012-07-10

7.  Development of Natural-Based Bone Cement for a Controlled Doxorubicin-Drug Release.

Authors:  Rebecca Marie Dewhurst; Annachiara Scalzone; Joseph Buckley; Clara Mattu; Kenneth S Rankin; Piergiorgio Gentile; Ana Marina Ferreira
Journal:  Front Bioeng Biotechnol       Date:  2020-07-09
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.